JO
SURF

John Overdeck’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

John Overdeck’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,317
Closed -$33.3K – 3360
2023
Q2 		$33.3K Sell
38,317
-9,093
-19% -$6.48K ﹤0.01% 2868
2023
Q1 		$33.1K Buy
47,410
+21,248
+81% +$17.2K ﹤0.01% 2802
2022
Q4 		$21.5K Sell
26,162
-128,633
-83% -$127K ﹤0.01% 2673
2022
Q3 		$161K Sell
154,795
-24,426
-14% -$39K ﹤0.01% 2154
2022
Q2 		$294K Buy
+179,221
New +$372K ﹤0.01% 2033
2021
Q2 		– Sell
-76,411
Closed -$596K – 4716
2021
Q1 		$596K Buy
76,411
+28,656
+60% +$286K ﹤0.01% 2769
2020
Q4 		$441K Sell
47,755
-214,593
-82% -$1.87M ﹤0.01% 2604
2020
Q3 		$1.81M Sell
262,348
-129,422
-33% -$785K 0.01% 1359
2020
Q2 		$2.57M Buy
+391,770
New +$1.41M 0.01% 974

John Overdeck's SURF Position: Q3 2023 in Review

John Overdeck sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 38,317 shares — an estimated $33.3K sold.

John Overdeck first reported a position in SURF in Q2 2020 and held it in 9 quarters. The position peaked at $2.57M in Q2 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • John Overdeck reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • John Overdeck sold 38,317 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $33.3K.
  • John Overdeck first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • John Overdeck's Surface Oncology, Inc. Common Stock position peaked at $2.57M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.